Top Buy
Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.68 | €25.20 | 98.839% |
Ensign Group Inc. | 8 | 0 | 0 | 0 | €109.00 | €116.50 | 6.877% |
United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
Taro Pharmaceutical Industries Ltd | 7 | 0 | 0 | 0 | €39.40 | - | - |
Merit Medical Systems | 16 | 0 | 3 | 0 | €70.50 | €86.90 | 23.258% |
Select Medical Holdings | 5 | 0 | 2 | 0 | €26.00 | €36.31 | 39.673% |
Haemonetics Corp. | 7 | 0 | 0 | 0 | €84.50 | €97.90 | 15.860% |
Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €99.52 | - | - |
Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
Korian S.A. | 1 | 0 | 1 | 0 | €2.39 | - | - |
Amedisys Inc. | 14 | 0 | 1 | 0 | €84.00 | €92.26 | 9.833% |
Icon plc | 18 | 0 | 0 | 0 | €280.90 | €319.67 | 13.802% |
QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
LivaNova plc | 9 | 0 | 2 | 0 | €57.00 | €66.59 | 16.829% |
Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
Xencor Inc. | 9 | 1 | 0 | 0 | €18.70 | €31.74 | 69.727% |
Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
Neurocrine Bioscience | 27 | 0 | 4 | 0 | €130.70 | €140.34 | 7.376% |
Tenet Healthcare | 28 | 0 | 5 | 0 | €112.00 | €121.67 | 8.631% |
Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
Bruker Corp. | 7 | 1 | 0 | 0 | €65.08 | €85.68 | 31.660% |
Medpace Holdings Inc | 9 | 0 | 0 | 0 | €365.20 | €421.61 | 15.445% |